New book by Larry Connors Click here Improve your trading - See how
The Intel Health Guide, which received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) in July, is a comprehensive personal health system that combines an in-home patient device - the Intel Health Guide PHS6000 - as well as an online interface - the Intel Health Care Management Suite - allowing clinicians to monitor patients in their homes and manage care remotely.
"The Health Guide is a step forward in offering more personalized and effective management of chronic health conditions in the home," said Louis Burns, vice president and general manager of the Intel Digital Health Group. "Intel has spent years researching the needs of both caregivers and patients, and we are now moving to launch a series of products that will help extend care from the hospital to the home. Our products will help address the challenges of an aging population and rising rates of chronic disease."
Intel is collaborating with health care industry leaders around the world to validate the clinical benefits of the Health Guide for a wide range of chronic disease conditions and health and wellness applications. Pilot studies in the United States are currently planned with health care organizations such as Aetna, Erickson Retirement Communities, Providence Medical Group in Oregon and SCAN Health Plan. The goals and objectives are to assess how the Health Guide integrates with different care management models in the home.
These first studies focus on the ability to demonstrate improved health outcomes for conditions such as heart failure, diabetes, hypertension and chronic obstructive pulmonary disease.
Customers such as Advanced Warning Systems, Inc., (AWS), a provider of health care discovery products and web-based services, monitor people for acute cardiovascular symptoms that can cause sudden death. AWS will use the Intel Heath Guide to connect with a targeted class of users, including retired athletes and post-war veterans suffering from post traumatic stress disorder (PTSD), with the highest incidence of cardiovascular related illnesses.
The Health Guide promotes greater patient engagement and more efficient care management by enabling communication between patients and health care professionals and providing clinicians with access to the most current, actionable data.
This solution offers interactive tools for personalized care management and includes vital sign collection, patient reminders, surveys, multimedia educational content, and feedback and communications tools, such as video conferencing and alerts. Clinicians have ongoing access to data so that they can better manage each patient's conditions while patients benefit from customized care in the comfort of their own living room.
Intel is working with leading health care organizations that have an understanding of health care delivery to develop unique patient care plans as well as multimedia educational content for chronic conditions. Specifically, Intel is working with the Mayo Clinic to have licensed educational content from MayoClinic.com made available to customers using the Health Guide. In addition, Intel is working with the American Heart Association to create care plans based on the organization's treatment guidelines for a pilot project for the ongoing management of patients with heart failure. The intent is to help health care professionals monitor patients and remotely manage their care in accordance with science guidelines and also to provide patients with ready access to credible and targeted education material. Intel has also hired a team of clinical experts to provide a range of professional services to enable health care organizations to successfully integrate the personal health system into their current disease management programs and models of care.
Additionally, Intel plans to use the core technology components of the solution to build products targeted for new areas such as independent living and programs for health and wellness management and to support new devices such as mobile phones and handhelds.
American Medical Alert Corporation, a national provider of remote patient monitoring devices and 24/7 health care communication services, will be the first U.S. market channel partner for the Intel Health Guide. By adding the Intel Health Guide to its portfolio of offerings, AMAC will be further equipped to provide its customers with the best in care management technologies. The Health Guide is designed to be used by health care professionals to manage their patients at home and is not currently available for general consumer purchase.
For More Information
For information on how to purchase this product, visit www.intel.com/healthcare/ps/healthguide/wtb.htm.
For more information on the Intel Health Guide, visit www.intel.com/healthcare/telehealth.
To learn more about Intel in health care, go to www.intel.com/healthcare.
For contact information and partner quotes please download PartnerContactsQuotes.pdf (pdf/53KB).
About Intel
Intel (NASDAQ: INTC), the world leader in silicon innovation, develops technologies, products and initiatives to continually advance how people work and live. Additional information about Intel is available at www.intel.com/pressroom and blogs.intel.com.
Intel is a trademark of Intel Corporation or its subsidiaries in the United States and other countries.
* Other names and brands may be claimed as the property of others.
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403
© Copyright 2009 The Connors Group, Inc.
